Literature DB >> 21046311

p53 abnormality and tumor invasion in patients with malignant astrocytoma.

Hiroyuki Momota1, Yoshitaka Narita, Yuko Matsushita, Yasuji Miyakita, Soichiro Shibui.   

Abstract

Malignant astrocytomas are characterized by diffusely infiltrating nature, and the abnormality of p53 is a cytogenetic hallmark of astrocytic tumors. To elucidate the relationship between p53 abnormality and invasiveness of the tumors, we studied mutation and protein expression of p53 in 48 consecutive patients with malignant astrocytoma (14 anaplastic astrocytomas and 34 glioblastoma multiformes). The tumors were classified into three categories according to the features of magnetic resonance imaging, and 5, 7, and 36 tumors were classified into diffuse, multiple, and single type, respectively. We then examined how these tumor types correlate with MIB-1 staining index, TP53 gene mutation, and p53 protein expression. We found that p53 immunopositivity or TP53 mutation was frequently observed in diffuse and multiple types. These abnormalities of p53 were also associated with high MIB-1 staining index and strong expression of vascular endothelial growth factor. Furthermore, diffuse- and multiple-type tumors were significantly correlated with poor progression-free survival, whereas only multiple-type tumors were significantly correlated with poor overall survival. As diffuse and multiple features on imaging modalities represent invasive characteristics of the tumors, p53 abnormalities may affect the invasive and aggressive nature of malignant astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046311     DOI: 10.1007/s10014-010-0272-x

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  9 in total

1.  The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.

Authors:  Jun Guo; Chengjun Yao; Hong Chen; Dongxiao Zhuang; Weijun Tang; Guang Ren; Yin Wang; Jinsong Wu; Fengping Huang; Liangfu Zhou
Journal:  Acta Neurochir (Wien)       Date:  2012-06-23       Impact factor: 2.216

2.  Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors.

Authors:  Shingo Takano; Yukinari Kato; Tetsuya Yamamoto; Mika Kato Kaneko; Eiichi Ishikawa; Yuta Tsujimoto; Masahide Matsuda; Kei Nakai; Ryo Yanagiya; Shunpei Morita; Koji Tsuboi; Akira Matsumura
Journal:  J Neurooncol       Date:  2012-03-07       Impact factor: 4.130

3.  Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.

Authors:  Yuki Ohkawa; Hiroyuki Momota; Akira Kato; Noboru Hashimoto; Yusuke Tsuda; Norihiro Kotani; Koichi Honke; Akio Suzumura; Keiko Furukawa; Yuhsuke Ohmi; Atsushi Natsume; Toshihiko Wakabayashi; Koichi Furukawa
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

4.  High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Authors:  Jana Smardova; Kvetoslava Liskova; Barbora Ravcukova; Lenka Kubiczkova; Sabina Sevcikova; Jaroslav Michalek; Miluse Svitakova; Vaclav Vybihal; Leos Kren; Jan Smarda
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

5.  Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.

Authors:  Dayane B Koshiyama; Patrícia Trevisan; Carla Graziadio; Rafael F M Rosa; Bibiana Cunegatto; Juliete Scholl; Valentina O Provenzi; Alexandre P de Sá; Fabiano P Soares; Maíra C Velho; Nelson de A P Filho; Ceres A Oliveira; Paulo R G Zen
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

Review 6.  Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?

Authors:  M Hingorani; W P Colley; S Dixit; A M Beavis
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

7.  Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.

Authors:  Carlos A Fedrigo; Ivana Grivicich; Daniel P Schunemann; Ivan M Chemale; Daiane dos Santos; Thais Jacovas; Patryck S Boschetti; Geraldo P Jotz; Aroldo Braga Filho; Adriana B da Rocha
Journal:  Radiat Oncol       Date:  2011-11-11       Impact factor: 3.481

8.  Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.

Authors:  Hátylas Azevedo; André Fujita; Silvia Yumi Bando; Priscila Iamashita; Carlos Alberto Moreira-Filho
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

9.  Immunohistochemical classification of primary and secondary glioblastomas.

Authors:  Kyu Sang Lee; Gheeyoung Choe; Kyung Han Nam; An Na Seo; Sumi Yun; Kyung Ju Kim; Hwa Jin Cho; Sung Hye Park
Journal:  Korean J Pathol       Date:  2013-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.